BioNTech Plans Modular Factories in Africa to Boost COVID Vaccine Availability
Headline from NBC 5 Dallas-Fort Worth
BioNTech has been criticized by some campaign groups for refusing to suspend its vaccine patents and let rivals manufacture the shots as part of an effort to make them more widely accessible.
NBC 5 Dallas-Fort Worth's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
BioNTech has been criticized by some campaign groups for refusing to suspend its vaccine patents and let rivals manufacture the shots as part of an effort to make them more widely accessible.
BioNTech announced on Wednesday that it plans to create manufacturing facilities in Africa in order to bolster the company's ability to provide more essential medicines including the COVID-19 vaccine.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
BioNTech Plans Modular Factories in Africa to Boost COVID Vaccine Availability | Since Then